He had contributed much to the study of mediators and the physiology of the heart, and developed a number of physiological methods of studying the human organism.
Annette M. Taberner-Miller, Ph.D. (born 1973) is a Cuban American Neuroscientist studying the dynamics of neurotransmitter release in the spinal cord at the Miami Project to Cure Paralysis.
Katz won the Nobel for his discovery with Paul Fatt that neurotransmitter release at synapses is "quantal"—that is, that at any particular synapse the amount of neurotransmitter released is never less than a certain amount, and if more is always an integral number times this amount.
Neuropeptide, a protein sequence which acts as a hormone or neurotransmitter
L-DOPA, (S)-3,4-dihydroxyphenylalanine, a precursor of a neurotransmitter
This is probably caused by a sudden decrease in the release of neurotransmitters from the sympathetic nerves to the muscular coat of the arteriovenous anastomoses due to local cold.
This protein is also known as Lynx2, a member of the Lynx family of neurotransmitter receptor-binding proteins.
NMDAR antagonists fall into four categories: Competitive antagonists, which bind to and block the binding site of the neurotransmitter glutamate; glycine antagonists, which bind to and block the glycine site; noncompetitive antagonists, which inhibit NMDARs by binding to allosteric sites; and uncompetitive antagonists, which block the ion channel by binding to a site within it.
The dual effect of seletracetam is an overall decrease in the amount of action potential due to binding at N-type channels, which prevents over-excitation of the neuron, as well as a decrease in neurotransmitter release as a product of cellular excitation due to the interaction of the drug with SV2A, which reduces the spread of excitation to nearby cells.